Two-photon excited photoluminescence lifetime imaging studies on individual gelatin-coated gold nanorods

Craciun, Ana-Maria; Susu, Laurentiu; Baia, Monica

doi:10.1016/j.molstruc.2021.130785

Cited by 1 publication

(1 citation statement)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Researchers used this method to examine the ability of variously shaped gold NPs covered in gelatin to contrast images and their effectiveness as a reliable contrast agent for visualizing NIH: OVCAR-3 cells. Gelatin-coated gold NPs have been identified as potent contrast agents for fluorescence imaging in clinical therapy and diagnosis ( Craciun et al, 2021 ). Due to the limited number of studies performed on image contrast agents based on NPs for the identification of ovarian tumors, further investigation of the imaging-related characteristics of NPs is necessary to identify broader opportunities for imaging tumors.…”

Section: Nanotechnology Approaches For Diagnosis Of Ocmentioning

confidence: 99%

New trends in diagnosing and treating ovarian cancer using nanotechnology

Zhang

Ding

Zhang

et al. 2023

Front. Bioeng. Biotechnol.

View full text Add to dashboard Cite

Ovarian cancer stands as the fifth most prevalent cancer among women, causing more mortalities than any other disease of the female reproductive system. There are numerous histological subtypes of ovarian cancer, each of which has distinct clinical characteristics, risk factors, cell origins, molecular compositions, and therapeutic options. Typically, it is identified at a late stage, and there is no efficient screening method. Standard therapies for newly diagnosed cancer are cytoreductive surgery and platinum-based chemotherapy. The difficulties of traditional therapeutic procedures encourage researchers to search for other approaches, such as nanotechnology. Due to the unique characteristics of matter at the nanoscale, nanomedicine has emerged as a potent tool for creating novel drug carriers that are more effective and have fewer adverse effects than traditional treatments. Nanocarriers including liposomes, dendrimers, polymer nanoparticles, and polymer micelles have unique properties in surface chemistry, morphology, and mechanism of action that can distinguish between malignant and normal cells, paving the way for targeted drug delivery. In contrast to their non-functionalized counterparts, the development of functionalized nano-formulations with specific ligands permits selective targeting of ovarian cancers and ultimately increases the therapeutic potential. This review focuses on the application of various nanomaterials to the treatment and diagnosis of ovarian cancer, their advantages over conventional treatment methods, and the effective role of controlled drug delivery systems in the therapy of ovarian cancer.

show abstract

Section: Nanotechnology Approaches For Diagnosis Of Ocmentioning

confidence: 99%